Abstract:Epidemiological studies suggest that increased intake of fruits and vegetables may be associated with a reduced risk of prostate cancer. Apigenin (4', 5, 7,-trihydroxyflavone), a common dietary flavonoid abundantly present in fruits and vegetables, has shown remarkable anti-proliferative effects against various malignant cell lines. However, the mechanisms underlying these effects remain to be elucidated. We investigated the in vivo growth inhibitory effects of apigenin on androgen-sensitive human prostate carcinoma 22Rv1 tumor xenograft subcutaneously implanted in athymic male nude mice. Apigenin was administered to mice by gavage at doses of 20 and 50 mug/mouse/day in 0.2 ml of a vehicle containing 0.5% methyl cellulose and 0.025% Tween 20 in two different protocols. In the first protocol, apigenin was administered for 2 wk before inoculation of tumor and was continued for 8 wk, resulting in significant inhibition of tumor volume by 44 and 59% (P<0.002 and 0.0001), and wet weight of tumor by 41 and 53% (P<0.05), respectively. In the second protocol, administration of apigenin began 2 wk after tumor inoculation and continued for 8 wk; tumor volume and wet weights of tumor were reduced by 39 and 53% (P<0.01 and 0.002) and 31 and 42% (P<0.05), respectively. The tumor inhibitory effect of apigenin was more pronounced in the first protocol of extended treatment, which was associated with increased accumulation of human IGFBP-3 in mouse serum along with significant increase in IGFBP-3 mRNA and protein expression in tumor xenograft. Apigenin intake by these mice also resulted in simultaneous decrease in serum IGF-I levels and induction of apoptosis in tumor xenograft. Importantly, tumor growth inhibition, induction of apoptosis, and accumulation of IGFBP-3 correlated with increasing serum and tumor apigenin levels. In both studies, animals did not exhibit any signs of toxicity or reduced food consumption. In cell culture studies, apigenin treatment resulted in cell growth inhibition and induction of apoptosis, which correlated with increased accumulation of IGFBP-3 in culture medium and cell lysate. These effects were associated with significant reduction in IGF-I secretion; inhibition of IGF-I-induced cell cycle progression and insulin receptor substrate-1 (IRS-1) tyrosine phosphorylation, along with an increase in sub-G1 peak by apigenin. Further, treatment of cells with IGFBP-3 antisense oligonucleotide reversed these effects and attenuated apigenin-mediated inhibition of IRS-1 phosphorylation conferring inhibitory effects of apigenin on IGF-signaling. This study presents the first evidence that the in vitro and in vivo growth inhibitory effects of apigenin involve modulation of IGF-axis signaling in prostate cancer.

The Therapeutic and Preventive Effect of RRR-alpha-vitamin E Succinate on Prostate Cancer Via Induction of Insulin-Like Growth Factor Binding Protein-3

Effect of laminin tyrosine-isoleucine-glycine-serine-arginine peptide on the growth of human prostate cancer (PC-3) cells in vitro.

Vitamin E Succinate Inhibits Growth and Induces Apoptosis of Prostate Cancer Cell Line PC-3

RRR-alpha-Vitamin E Succinate Potentiates the Antitumor Effect of Calcitriol in Prostate Cancer Without Overt Side Effects

Rrr-Alpha-Tocopheryl Succinate Inhibits Human Gastric Cancer Sgc-7901 Cell Growth By Inducing Apoptosis And Dna Synthesis Arrest

alpha-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis.

Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism

Vitamin D, Intermediary Metabolism and Prostate Cancer Tumor Progression

Vitamin E Succinate Exerts Anti-Tumour Effects on Human Cervical Cancer Cells Via the CD47-SIRPɑ Pathway Both in Vivo and in Vitro

Inhibitory Effect of Vitamin E Succinate on Experimental Breast Cancer in Nude Mice

Inhibitory Effects of RRR-α-tocopheryl Succinate on Benzo(a)pyrene (B(a)p)-Induced Forestomach Carcinogenesis in Female Mice

Protective Macroautophagy is Involved in Vitamin E Succinate Effects on Human Gastric Carcinoma Cell Line Sgc-7901 by Inhibiting Mtor Axis Phosphorylation

The Suppressive Effect and Signal Pathway of Vitamin E on the Expression of Minichromosome Maintenance Protein 4 in Prostate Cancer Cells

Growth Inhibition of Human Breast Cancer by Vitamin E Succinate Combined with Chemotherapeutic Drugs

Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis

The Effects of Vitamin E Succinate on the Expression Ofc-Jungene and Protein in Human Gastric Cancer SGC-7901 Cells

Growth Inhibition and Apoptosis of Human Colon Cancer Cells Induced by Vitamin E Succinate

Vitamin E Succinate Inhibits Proliferation and Induces Apoptosis in Human Esophageal Carcinoma Cells TE-1 and Eca-109

In vivo experiment of the effect of vitamin E succinate on expression of Fas and apoptosis induction in Bcap-37 breast cancer cells

Up‐regulation of insulin‐like growth factor binding protein‐3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice

Induction of apoptosis in human renal cell carcinoma cells by vitamin E succinate in caspase-independent manner.